Taming the 'wild, Wild West' of e-cigarettes
The following opinion piece includes the collective thoughts of several MD Anderson prevention researchers
Recently, the Food and Drug Administration (FDA) took some long-overdue steps when it announced its proposed regulations on electronic cigarettes.
For the past few years, the booming e-cigarette industry, which saw sales jump from $500 million in 2012 to nearly $2 billion today, has operated with little oversight. The...
Are we over imaging?
Advancements in imaging have dramatically altered all aspects of cancer care — from diagnosis and treatment to surveillance and prevention...
The cancer leaders of tomorrow
While many times, the achievements of senior faculty members receive the greatest attention, MD Anderson is also taking steps to highlight...
An alternative to chemo?
A newly approved drug for the treatment of chronic lymphocytic leukemia (CLL), studied in clinical trials at MD Anderson, is showing significant promise. In February, the U.S. Food and Drug Administration granted accelerated approval of Imbruvica, for use in previously treated CLL patients.
"Ibrutinib produces durable responses in patients after other treatments have failed, and with very little toxicity. The main side effect...
Building a personalized approach to cancer therapy
In 2011, the MD Anderson Cancer Center received a $150 million gift — the largest in the history of the institution — from the Khalifa Bin...
Immunotherapy gets top billing at AACR
The G.H.A. Clowes Memorial Award is the oldest honor bestowed on a researcher by the American Association for Cancer Research. It's been given...
Our immunotherapy allies
The promise of immunotherapy, drugs that stimulate the body's immune system to fight cancer, can be witnessed by observing the string of development...
Additional AACR highlights
Additional presentations of note at this year's American Association for Cancer Research Annual Meeting:
Reclassifying low-grade brain...MD Anderson experts share updates at AACR Annual Meeting
The 54th annual meeting of the American Association for Cancer Research opens this morning in San Diego with educational sessions and workshops...